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previous transesophageal CV attempts. These investigations em-
ployed esophageal CV catheters, which were mostly positioned under
fluoroscopic control (3–5). Some included atrial CV electrodes (3,6)
or delivered shocks between esophageal and cutaneous electrodes (4,5)
or mere esophageal electrodes (5,7). The approach presented herein
also differs from a recent report on transesophageal CV in patients
with CV electrodes embedded permanently in a novel TEE-probe (8)
as the disposable CV electrode sheath can be affixed to any conven-
tional TEE probe already available in the hospitals. It also enables the
continued use of disposable sheaths to cover the TEE probe for
hygienic reasons as practiced in many hospitals. By contrast,
TEE-CV electrodes permanently integrated into a TEE probe would
prevent the use of isolating plastic sheaths.
Safety of the approach is an important concern. Chronic
follow-up of the dogs with high-energy TEE-CV did not reveal
esophageal damage. Because esophagoscopies were not undertaken
in the six-week interval between CV and final examination, we
cannot exclude that initial hyperemia in two animals transiently
progressed to erosive esophagitis or ulceration. The lack of chronic
esophageal damage, however, provides evidence that TEE-CV
may be performed safely in patients. Finally, because AF was
acutely induced we cannot determine whether TEE-CV would be
as effective in chronic AF or with underlying atrial pathology.
In brief, TEE-CV of AF led to a four-fold reduction of CV
energy compared to external CV and was equally effective as
TV-CV. The CV electrode can be attached to conventional TEE
probes and may allow CV and thrombus exclusion during one
sedation.
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Letters to the Editor
Magnetic Resonance Imaging
in Patients With Cardiac Pacemakers
We read with great interest the study “Magnetic Resonance
Imaging and Cardiac Pacemaker Safety at 1.5-Tesla” by Martin et
al. (1). We agree that with the opinion that pacemakers represent
an absolute contraindication to magnetic resonance imaging
(MRI) should be reevaluated and that MRI in patients with
implanted pacemakers can be performed safely in carefully selected
circumstances when appropriate imaging strategies are used.
However, the statement that “pacemakers automatically enter
the asynchronous mode when in the presence of a powerful static
magnetic field” is false and leads to an underestimation of the
MRI-related risks in pacemaker patients. Our experimental and
clinical data and recent studies have shown that the reed switch
remains open in up to 50% of all orientations of the pacemaker
device even in the strong static magnetic field of a 1.5-t magnetic
resonance system (2,3). This may have important clinical implica-
tions, because if the reed switch is open potentially harmful false
inhibition or false triggering of the pacemaker by the pulsed
Figure 2. Atrial cardioversion thresholds (ACVT). *p  0.001 vs. external
cardioversion (CV).
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electromagnetic magnetic resonance fields may occur. Complete
inhibition of pacemaker output in pacemaker-dependent patients
and/or false triggering with tracking to the upper rate limit in
patients with reduced left ventricular function may be detrimental.
Therefore, we cannot support the approach of Martin and
co-workers—that is, to leave the pacemaker sensing function
activated. In contrast, we recommend deactivating the sensing
function in pacemaker-dependent patients by programming the
pacemaker device to an asynchronous mode, to ensure continuous
pacing, and to program the pacemaker device to a sensing-only
mode (0X0) or subthreshold pacing in nonpacemaker-dependent
patients to avoid MRI-related triggering.
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REPLY
We thank Dr. Sommer and colleagues for their interest in our
work (1). We agree that the magnet mode of the pacemaker is not
always maintained during magnetic resonance imaging (MRI). We
have in fact observed this phenomenon during our experience.
This phenomenon is related to the position of the pulse generator
relative to the isocenter of the magnetic field. However, this does
not alter our recommendations for imaging these patients.
Their statement regarding the possibility of an open reed switch
leading to false inhibition and/or false triggering is valid. However,
it was for this reason that pacemaker-dependent patients were
excluded from our study. We were also concerned about thermo-
genic damage at the lead-tissue interface with subsequent loss of
capture, which would also be detrimental in pacemaker-dependent
patients. Finally, we did not alter pacemaker sensing, because in
our experience over-sensing on the atrial channel occurs extremely
infrequently.
Pacemaker-dependent patients can likely undergo MRI as long
as sensing is disabled. However, the possibility of thermogenic
damage and loss of capture cannot be overstated.
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RESTORE—From
Deduction to Leap of Faith
In a recent study in JACC by the RESTORE Investigators, the
researchers equate postoperative elevation in left ventricular ejection
fraction (LVEF) (29.6% to 39.5%) and decrease in left ventricular
end-systolic index (LVESI) (80 ml to 56 ml) to improved LV
function. However, an increase in LVEF and a decrease in LVESI are
geometric necessities of the operation, which involves a concentric
shrinking of the infarcted anterior/septal myocardial area with a
purse-string stitch, and closure of the small residual defect with an
oval patch. They are predicated within the notion of the ventricular
reduction itself, assuming the remaining sarcomeres continue their
usual function. To say that ventricular function is improved, one
would need data to show that stroke volume or, secondarily, pulmo-
nary artery pressures or cardiac output improved. None of these data
were provided; indeed, one would expect stroke volume and cardiac
output not to change, and pulmonary artery pressures to fall based on
Laplace’s law.
The investigators make a good case in their discussion that they
have helped their patients based on historical series involving
individual components of the operation in subjects with dilated
hearts (coronary artery bypass graft, ventricular aneurysmectomy,
mitral repair). But the leap from what is essentially a deductive
tautology (A  A) to their empiric finding of improved clinical
symptoms requires hemodynamic data for inductive reasoning
about cause and effect (1).
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The RESTORE registry was accumulated to confirm the extensive
experience of Dor and his colleagues, which dates back about 20
years. The primary reason for presenting these data was to
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